全文预览已结束
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
See online version for legend and references.930 Cell 133, May 30, 2008 2008 Elsevier Inc. DOI 10.1016/j.cell.2008.05.020 SnapShot: p53 Posttranslational Modifications Jan-Philipp Kruse and Wei Gu Institute for Cancer Genetics and Department of Pathology and Cell Biology, Columbia University, New York, New York, USA Site Modifying EnzymeCellular Function Disease or Knockout Phenotype Phosphorylation N-Terminal: S6, S9, S15, T18, S20 ATM, DNAPK, CK1 ERKs, ATR, p38 kinase, mTOR, Chk1/Chk2, JNK, MAPKAP2, Hipk4 Activated by DNA damage, UV light, ionizing radiation, replicative senes- cence, or phosphatidylcholines. N-terminal phosphorylation causes p53 stabilization by inhibiting the p53- MDM2 interaction. Knockin mice carrying separate analogs to human Ser18/ Ser23 mutation are phenotypically normal. Thymocytes from Ser18 mutant mice are susceptible to ionizing radiation-induced apoptosis, whereas S23 mutation in ES cells and MEFs is dispensable for p53 stabilization and activation. Ser18/Ser23 double mutant knockin mice dis- play reduced apoptosis in thymocytes and develop some malignancies. Very rare mutations reported in human tumors. S33, S37, S36, S 46, T55, T81 GSK3 , p38 kinase, ATR, DNAPK, JNK, AMPKalpha HIPK2, DYKR2, ERK2, TAF1 Activation by UV light (S33, S37, S46, Thr81), H 2O2 treatment (S33), -radiation, DNA damage (S37), and glucose deprivation (Ser46). Phosphorylation leads to stabilization and promotes p53 transcriptional activity to regulate p53-mediated cell-cycle arrest and apoptosis. Very rare mutations reported in human tumors. S149, T150, T155 CSN-associated kinase complex Activated in unstressed cells. Promotes p53 degradation. Very rare mutations reported in human tumors. S315, S376, S378, S392 PKC, PKR, GSK3 FACT-CK2, p38 kinase CDK (cdc2/ck2), AURKA Activated by UV light (CDK/GSK3 , FACT-CK2, p38 kinase), AURKA over- expression, and interferon signaling (PKR) S351 phosphorylation activates p53-mediated transcription to regulate apoptosis and cell cycle. PKC constitutively phosphorylates p53 at S376 and S378 in unstressed cells, IR stress leads to dephosphorylation. S392 phosphorylation promotes sequence-specific p53 DNA binding. Knockin of S392 mouse analog (S389) is phenotypically normal. p53 transcriptional activation is partially compro- mised in cells isolated from knockin mice. Very rare mutations have been reported for individual sites in human tumors. Acetylation K120hMOF, Tip60 K120 acetylation is promoted upon DNA damage. Acetylation at K120 is crucial for p53-mediated apoptosis via BAX and PUMA. K120 acetylation is dispensable for cell-cycle regulation and growth arrest. p53 acetylated at K120 accumulates at proapoptotic target genes. K120 mutations to Arg, Glu, or Met have been reported in human tumors. Effect of K120 point mutations in animal models will need to be determined. K164p300 / CBP Acetylation is induced by DNA damage and HDAC inhibitor treatment. K164 mutation does not affect DNA binding. Acetylation is required for growth arrest and apoptosis. Mutations of K164 are reported in human tumors. K320PCAF Acetylation of K320 by PCAF is induced by DNA damage. K320 acetylation increases p53 DNA-binding capability. p53 K320 acetylation state effects transcriptional activity. Knockin experiments of the mouse homolog K317R, mim- icking p53 unacetylated at K320, enhance p53-mediated apoptosis after DNA damage in all cell types analyzed. Very rare mutations reported in human tumors. K370, K372, K373, K381, K382, K386 p300/CBP C-terminal acetylation levels are enhanced upon stress. Acetylation levels increase upon HDAC inhibitor (TSA, nicotinamide) treatment. C-terminal acetylation enhances p53 sequence-specific DNA-binding activity. Acetylation promotes CBP/p300 recruitment and target gene activation. p53 stability is affected by C-terminal acetylation due to inhibition of ubiq- uitination at acetylated lysines. p53 is deacetylated by HDACs and Sirt1. Deacetylation by Sirt represses p53-dependent apoptosis in response to DNA damage and oxidative stress. Knockin experiments in mice introducing p53 with the C-terminal lysines mutated (6KR/7KR) produced viable and phenotypically normal animals. C-terminal KR stem cells, MEFs, and thymocytes show normal p53 stabilization after DNA damage, yet p53 target gene expression is impaired in promoter-specific fashion. Very rare mutations reported in human tumors. Ubiquitination and UB-like Modification UB: K370, K372, K373, K381, K382, K386 MDM2 Arf-BP1, COP1, and Pirh2 MDM2-mediated polyubiquitination leads to p53 degradation. monoubiquitination of p53 results in nuclear export. Arf-BP1, COP1, and Pirh2 all ubiquitinate p53 and target it for proteasomal degradation. HAUSP deubiquitinates p53 as well as regulates p53 via deubiquitination of MDM2 and MDMX. Knockin experiments in mice introducing p53 with the C-terminal lysines mutated (6KR/7KR) produced viable and phenotypically normal animals. C-terminal KR stem cells, MEFs, and thymocytes display normal p53 stabilization after DNA damage, yet p53 target gene expression is impaired in a promoter-specific fashion. Knockin experiments of the mouse homolog K317R, mim- icking p53 unacetylated at K320, enhance p53-mediated apoptosis after DNA damage in all cell types analyzed. Very rare mutations reported in human tumors. SUMO: K386PIAS, PIASx Functional consequences are unclear. Both activation and suppression of transcriptional regulation have been reported. NEDD8: K320 K321, K370, K372, K373 FBXO11, MDM2 Neddylation of p53 inhibits transcriptional activity. Methylation K370Smyd2 Inhibition of p53-promoter association resulting in p53 target gene repression. Knockin experiments in mice introducing p53 with mutated C-terminal lysines (6KR/7KR) produced viable and pheno- typically normal animals. C-terminal KR stem cells, MEFs, and thymocytes show normal p53 stabilization after DNA damage, yet p53 target gene expression is impaired in promoter-specific fashion. Modest effect of C-terminal lysine mutant knockins implies limited effect of p53 regulation via single site metylation. Very rare mutations reported in human tumors. K372Set7/9 Methylation stabilizes p53 and promotes nuclear localization to upregulate p53 target gene expression. Blocks Smyd- mediated K370 methylation. K382Set8/PR-Set7 Suppresses p53 mediated transcription. Augments proapoptotic and checkpoint activation. Others O-GlcNAc: Ser149 O-GlcNAc transferase, O-GLcNAcase Stabilization of p53 by blocking ubiquitination-mediated proteolysis. Modification prevents T155 phosphorylation. In vivo role of these modifications is not yet determined. Very rare mutations reported in human tumors. ADP-ribosylation: E258, D259, E271 PARP-1 ADP-ribosylation prevents p53-Crm1 interaction, resulting in nuclear ac- cumulation of p53 due to inhibition of nuclear export of p53. SnapShot: p53 Posttranslational Modifications Jan-Philipp Kruse and Wei Gu Institute for Cancer Genetics and Department of Pathology and Cell Biology, Columbia University, New York, New York, USA 930.e1 Cell 133, May 30, 2008 2008 Elsevier Inc. DOI 10.1016/j.cell.2008.05.020 Since p53 was cloned and subsequently characterized as a tumor suppressor more the 20 years ago, more than 40,000 publications have been published relating to this protein. A great majority of this scientific literature focuses on the intricate details of p53 regulation by posttranslational modifications. Phosphorylation, the first posttrans- lational modification of p53 identified, was established as a positive regulator of p53 via modification at multiple sites by an ever-growing number of kinases activated by numerous stress signals. Subsequently, acetylation and ubiquitination have been established as major regulators of p53 by regulating p53 transcriptional activity and stabil- ity, respectively. More recently, other modifications, such as sumoylation, neddylation, methylation, and glycosylation, have been reported. Although the cellular effects of many modifications are established, mouse models using site-specific knockin approaches imply that some of these modifications are to some degree redundant. These findings raise the possibility that aspects of the p53 posttranslational regulatory network are redundant yet indispensable for exact and precise control of p53 activity upon stress-induced stimulation. REFEREnCES Bode, A.M., and Dong, Z. (2004). Post-translational modification of p53 in tumorigenesis. Nat. Rev. Cancer 4, 793805. Brooks, C.L., and Gu, W. (2003). Ubiquitination, pho
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 临床表型多组学标记物专用元数据数据字典
- 三年级数学两位数乘两位数笔算题综合测试例题带答案
- 两位数加两位数计算竞赛测试模拟题
- 2024年化工自动化控制仪表证模拟考试题库及化工自动化控制仪表理论考试试题
- 化学危险品管理制度 易制毒危险品管理制度六篇
- 2024年03月杭州市西湖区慈善联合总会2024年招考1名工作人员笔试参考题库附带答案详解
- 2024年03月广东省汕尾红海湾经济开发区卫生健康系统2024年专项公开招聘1名大学生乡村医生笔试参考题库附带答案详解
- 2024年03月安徽省泾县2024年度公开引进60名“政聘企培”事业单位储备人才笔试参考题库附带答案详解
- 2024年03月四川省泸州市市属事业单位2024年上半年公开考试招聘23名工作人员1笔试参考题库附带答案详解
- 2024年03月云南省祥云县2024年招募2名基础教育银龄教师1笔试参考题库附带答案详解
- 有余数的除法找规律解决问题市公开课一等奖省名师优质课赛课一等奖课件
- 创伤的救治流程【课件】
- 2023民营企业500强名单
- 提高钢结构厚型防火涂料喷涂施工质量合格率
- 上海户外广告设施设置申请表
- 2023年最新的筑牢中华民族共同体意识研讨会发言材料
- 河道治理工程地质勘察报告
- 医院各科室医院感染管理质量考核评分标准
- 过程控制-方康玲主编-课后习题答案
- 前海双界河项目“三防”安全监理细则-最终版
- 高固丁苯胶乳项目服务质量管理方案(参考)
评论
0/150
提交评论